Correspondence  by unknown
long-term temporal pattern of arrhythmia recurrence is a neglected
area of research and warrants further investigation.
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REPLY
We appreciate the interest of Wood et al. in our recently published
paper on electrical storm in patients with implantable cardioverter-
defibrillators (ICDs) (1). In their comments, they reemphasize the
importance of defining electrical storm based on temporal patterns
of arrhythmia clustering. As stated in our report (1), the precise
definition of this syndrome is still evolving; therefore, we adhered
to the most commonly used definition (2,3), realizing that it is still
somewhat arbitrary. Specifically, we are aware of the findings of
Wood et al. (4) indicating that two episodes of arrhythmia
detection by the ICD within 1 h may not necessarily be an unusual
finding. It appears important to note, however, that the median
number of arrhythmic episodes constituting electrical storm in our
patients was 17 within a single 24-h period leading to the need for
urgent therapy in most patients (1). Although we had to focus on
the timing of arrhythmia clustering, as with any definition of
electrical storm, the clinical picture substantially contributed to the
definition in our series. Moreover, we were interested in several
other issues related to electrical storm, such as precipitating factors,
therapeutic measures and potential prognostic implications. In
summary, we agree with Wood et al. (4) that more research is
needed to arrive at a more precise definition of electrical storm.
Our paper aimed to be one step in this direction.
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Use of Radial Artery Applanation Tonometry
Cameron et al. (1) reported clinical evaluation of a system that was
developed at St. Vincent’s Hospital by us (2) and that uses a
generalized transfer function to estimate the calibrated ascending
aortic pressure waveform from the radial artery pressure pulse
wave. The authors concluded that waveform analysis is of limited
value and that simple linear relations are sufficient to generate
central from cuff sphygmomanometric pressure values in individual
patients. We disagree.
In our own continuing evaluation, we have interrogated our
large data base (15,533 reports in 1,604 patients/subjects) and have
participated in studies where the estimated calibrated ascending
aortic waveform is compared to the pressure wave recorded
simultaneously by an intraarterial catheter from the ascending
aorta (3–5). In the first group of studies, we have obtained results
for systolic, diastolic and augmented pressure, which are very
similar to those reported by Cameron et al., and have shown the
same wide scatter in values of systolic and augmented pressure for
measured radial and estimated aortic waveforms. We take these
results to show the potential for generating more precise indexes of
left ventricular load and function than those available with the cuff
sphygmomanometer alone. In the second group of studies, we have
compared directly measured and estimated ascending aortic pres-
sure waves and indexes derived therefrom. We have shown a close
correspondence between estimated and measured aortic pressure
indexes in individual patients under control conditions and with
physiologic (Valsalva maneuver) and pharmacologic perturbations.
Indeed, correspondence between estimated and measured ascend-
ing aortic measurements generally fell within the AAMI (Associ-
ation for the Advancement of Medical Instrumentation) require-
ments for comparing different methods (6), whereas
correspondence between measured aortic and upper limb values
did not. Virtually identical results have been reported for a similar
system (7,8).
The evaluation by Cameron et al. (1) downplays the value of
information carried by the arterial pressure waveform and focuses
on cuff sphygmomanometric values. Their evaluation is limited by
the fact that all measurements (brachial cuff sphygmomanometry
with radial tonometry) were taken in the upper limb and none
from a central artery. Their comparison of “central” and peripheral
mean pressure was simply of the integrated calibrated radial
waveform against the mean brachial value determined by an
oscillometric method.
We remain convinced that use of the cuff sphygmomanometer
can be improved by incorporation of information provided by the
pulse waveform in the upper limb. Studies such as that by
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Cameron et al. (1) can only show the problems of an old approach
and the potential of the new. Presently, a consensus is emerging
that the central pressure waveform generated by the method we
have described (2) corresponds well to measured aortic pressure
under control conditions and during different perturbations in
individual patients (7–9).
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REPLY
In their letter, O’Rourke and Jiang suggest we downplay the
information carried by the arterial pressure waveform. We find this
a surprising interpretation of our work (1), which in fact discusses
aortic pressure augmentation as well as radial artery applanation
techniques in a broad context and which illustrates a number of
important general considerations of assessment of pressure aug-
mentation.
Our study of 262 treated hypertensive patients examined factors
contributing to aortic pressure augmentation as assessed using the
PWV Medical Blood Pressure Analysis System (PWV Medical,
Sydney, Australia), which uses a generalized transfer function and
radial artery tonometry. We found derived indexes of aortic
pressure augmentation to be significantly influenced by age,
gender, height and heart rate, but not by the different antihyper-
tensive agents used. To our knowledge, this study was the first to
use such devices, and we were particularly interested in the practical
advantages, if any, of transfer function approaches in comparison to
the more widely reported carotid artery applanation techniques. It
must be remembered that the use of transfer function techniques
creates an extra level of complexity that needs further cautious
evaluation before use in inferring central arterial variables.
O’Rourke et al. suggest our analysis is limited by a lack of central
pressure measurements; surely this is exactly the benefit proposed
for any useful noninvasive device. If central pressures are available,
radial applanation becomes superfluous. Similarly, we reject the
assertion that the so-called “wide scatter” of blood pressure values
can be used to infer a potential for improvement in measurement
of variables for which, noninvasively, no absolute value exists for
comparison. Comparison of derived central and brachial mean
pressures was as described; however, because this is the device’s
in-built basis for calibration and therefore of derived central blood
pressure, it seems strange that this is called into question by these
commentators.
It is premature and unsubstantiated to suggest the evolution of
any “consensus” regarding this type of method. Evaluation of the
validity of a generalized arterial transfer function, which, we stress,
was not the objective of the current study, requires simultaneous
invasive and noninvasive assessment of blood pressure. To date,
there has been inadequate published work on this topic, and it
should be noted that reports of invasive studies, which are
sometimes used to justify noninvasive transfer function techniques,
have been on small numbers and in select patient groups (2,3). In
particular, there appears to be no such prospective evaluation of the
PWV system, and we await with great interest the publication of
the data base referred to in Dr. O’Rourke’s letter.
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Beta-Blockers—A Forgotten Antiventricular
Tachy-Fibrillation Drug Class?
I have two questions regarding the recent study by Pires et al. (1).
Seventy-two percent of these patients were on antiarrhythmic
therapy, and is it not possible that proarrhythmic effects of these
drugs instituted the terminal episode of cardiac arrest, particularly
polymorphic ventricular tachy-fibrillation episodes. Second, would
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